International Clinical Trial: Efficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent Asthma

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07315555) titled 'Efficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent Asthma' on Dec. 18, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Tanta University

Condition: Community Acquired Pneumonia

Intervention: Dietary Supplement: Nigella sativa Oil Capsules (100 mg/kg/day) Dietary Supplement: Nigella sativa Oil Capsules (50 mg/kg/day)

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: January 1, 2026

Target Sample Size: 90

To kn...